1.
Early Presence of HIV-1 Subtype C in Washington, D.C
by Grossman, Zehava
AIDS research and human retroviruses, 2018-08, Vol.34 (8), p.680-684

2.
Large cluster outbreaks sustain the HIV epidemic among MSM in Quebec
by Brenner, Bluma G
AIDS (London), 2017-03-13, Vol.31 (5), p.707-717

3.
European guidelines on the clinical management of HIV-1 tropism testing
by Vandekerckhove, LPR, MD
The Lancet infectious diseases, 2011, Vol.11 (5), p.394-407

4.
Using Iterative Ridge Regression to Explore Associations Between Conditioned Variables
by Bar-Yaakov, Nimrod
Journal of computational biology, 2012-05-01, Vol.19 (5), p.54-518

5.
Early Presence of HIV-1 Subtype C in Washington, D.C
by Grossman, Zehava
AIDS research and human retroviruses, 2018-08-01, Vol.34 (8), p.68-684

6.
Transmission of drug-resistant HIV-1 in Europe remains limited to single classes
by Boucher, CAB
AIDS (London), 2008, Vol.22 (5), p.625-635

7.
Genetic variation at NNRTI resistance-associated positions in patients infected with HIV-1 subtype C
by GROSSMAN, Zehava
AIDS (London), 2004, Vol.18 (6), p.909-915

8.
Bayesian network analyses of resistance pathways against efavirenz and nevirapine
by DEFORCHE, Koen
AIDS (London), 2008, Vol.22 (16), p.2107-2115

9.
Ongoing HIV dissemination during HAART
by Grossman, Z
Nature medicine, 1999, Vol.5 (10), p.1099-1104

10.
Genotypic variation of HIV-1 reverse transcriptase and protease: comparative analysis of clade C and clade B
by GROSSMAN, Zehava
AIDS (London), 2001, Vol.15 (12), p.1453-1460

11.
Transient elevation of triiodothyronine caused by triiodothyronine autoantibody associated with acute Epstein-Barr-virus infection
by Shimon, Ilan
Thyroid (New York, N.Y.), 2003-02, Vol.13 (2), p.211-215

12.
Artifactual p53 point mutations: possible effect of gene secondary structure on PCR and direct sequence analysis
by Mor, Orna
The Lancet (British edition), 1992, Vol.340 (8829), p.1236-1236

13.
Metabolic Syndrome: Comparison of the Two Commonly Used Animal Models
by Oron-Herman, Mor
American journal of hypertension, 2008-09, Vol.21 (9), p.1018-1022

14.
The Role of Melatonin in the Pathogenesis of Hypertension in Rats With Metabolic Syndrome
by Leibowitz, Avshalom
American journal of hypertension, 2008-03, Vol.21 (3), p.348-351

15.
Effect of PPAR-γ Agonist on Adiponectin Levels in the Metabolic Syndrome: Lessons From the High Fructose Fed Rat Model
by Sharabi, Yehonatan
American journal of hypertension, 2007, Vol.20 (2), p.206-210

16.
Effect of PPAR-[gamma] Agonist on Adiponectin Levels in the Metabolic Syndrome: Lessons From the High Fructose Fed Rat Model
by Sharabi, Yehonatan
American journal of hypertension, 2007-02-01, Vol.20 (2), p.206
